Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

43.88 -0.23 (-0.52%)
Official Closing Price Updated: 7:00 PM EDT, Sep 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
30 31 Next >
News headline image
Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect ↗
Hedge funds are shifting towards stability and value by favoring the health care sector over booming tech stocks. 
Via Benzinga
News headline image
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today ↗
 
Via Benzinga
News headline image
Citadel Is The Most Successful Hedge Fund In History: Here Are Its Top Investment Picks ↗
 
Via Benzinga
News headline image
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Boston Scientific Options Trading: A Deep Dive into Market Sentiment ↗
 
Via Benzinga
News headline image
Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review ↗
The Dow led the major indexes higher. Big techs diverged on results. 
Via Investor's Business Daily
Topics Economy Stocks
Boston Scientific Corp. (NYSE: BSX) Sets New 52-Week High in Friday Session
Via Investor Brand Network
News headline image
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Stryker Stock Sees Relative Strength Rating Jump To 84 ↗
The Relative Strength (RS) Rating for Stryker stock jumped into a new percentile Thursday, with a rise from 76 to 84. 
Via Investor's Business Daily
News headline image
AT&T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
Key Takeaways From Boston Scientific Analyst Ratings ↗
 
Via Benzinga
News headline image
Biotech And Medtech Portfolio Notes On A Fed Day ↗
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23% 
Via Talk Markets
Topics Economy
News headline image
Preview: Boston Scientific's Earnings ↗
 
Via Benzinga
News headline image
Looking Into Boston Scientific's Recent Short Interest ↗
 
Via Benzinga
News headline image
Nasdaq, S&P 500 Slip Ahead Of Fed Meeting, Regional Banks Sink After NYCB Disappoints: What's Driving Markets Wednesday? ↗
Nasdaq down 1.4%, S&P 500 down 0.9%, Dow up: Volatile day on Wall Street as tech stocks react to disappointing earnings ahead of Fed meeting. 
Via Benzinga
Topics Economy Stocks
News headline image
Why Medical Devices Giant Boston Scientific Shares Are Rising Today ↗
Boston Scientific shares surge in premarket trading following strong Q4 results, beating revenue estimates, amid positive outlook for 2024. 
Via Benzinga
News headline image
Boston Scientific Surges On Its 'Impressive' First-Quarter Guidance ↗
The company expects sales to grow 7% to 9% organically, above expectations. 
Via Investor's Business Daily
News headline image
Stryker, Boston Scientific Score Earnings Beats, Extend Breakouts ↗
Shares of Stryker, Boston Scientific jumped early Wednesday after healthy earnings beats and price target hikes from analysts. 
Via Investor's Business Daily
Topics Earnings
News headline image
Demystifying Boston Scientific: Insights From 10 Analyst Reviews ↗
 
Via Benzinga
News headline image
Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser ↗
The record run of the market faces risk as the big tech earnings season got off to a negative start, casting cloud on profit outlook. 
Via Benzinga
Topics Economy
News headline image
Boston Scientific Corporation Should Continue Uptrend & Remain Supported ↗
Boston Scientific Corporation develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular segments. 
Via Talk Markets
News headline image
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst ↗
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
Via Benzinga
News headline image
Earnings Scheduled For January 31, 2024 ↗
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion. 
Via Benzinga
News headline image
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism? ↗
An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Chart Of The Day: Boston Scientific - Revenue Growth Potential ↗
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. 
Via Talk Markets
News headline image
Palo Alto Networks, Nvidia, And 2 Other Stocks Insiders Are Selling ↗
The Nasdaq 100 closed slightly lower on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
7 Healthcare Stocks Taking Medicine to the Next Level ↗
With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider. 
Via InvestorPlace
News headline image
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review ↗
The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut. 
Via Investor's Business Daily
Topics ETFs
News headline image
5 A-Rated Stocks to Buy ASAP in 2024 ↗
2024 is ushering in a new era for investors, and these top-notch, A-rated stocks to buy are likely to be market winners. Here's why. 
Via InvestorPlace
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.